Harris Associates
MRK icon

Harris Associates’s Merck MRK Stock Holding History

Harris Associates’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.49B Sell
12,366,933
-1,721,772
-12% -$199M 1.98% 15
2025
Q4 		$1.48B Buy
14,088,705
+4,265,097
+43% +$400M 1.87% 18
2025
Q3 		$824M Buy
9,823,608
+692,290
+8% +$57M 1.32% 31
2025
Q2 		$723M Buy
9,131,318
+1,661,958
+22% +$132M 1.18% 32
2025
Q1 		$670M Buy
7,469,360
+1,224,910
+20% +$114M 1.13% 33
2024
Q4 		$621M Buy
6,244,450
+3,301,429
+112% +$340M 0.82% 41
2024
Q3 		$334M Buy
+2,943,021
New +$350M 0.44% 52
2015
Q2 		– Sell
-24,979
Closed -$1.37M – 155
2015
Q1 		$1.37M Buy
24,979
+3,853
+18% +$218K ﹤0.01% 135
2014
Q4 		$1.15M Buy
21,126
+711
+3% +$39.6K ﹤0.01% 146
2014
Q3 		$1.16M Hold
20,415
– – ﹤0.01% 144
2014
Q2 		$1.13M Sell
20,415
-28,849
-59% -$1.57M ﹤0.01% 144
2014
Q1 		$2.67M Sell
49,264
-1,838,131
-97% -$95.2M ﹤0.01% 127
2013
Q4 		$90.1M Buy
1,887,395
+120,185
+7% +$5.49M 0.16% 100
2013
Q3 		$80.3M Buy
1,767,210
+2,480
+0.1% +$113K 0.16% 104
2013
Q2 		$78.2M Buy
+1,764,730
New +$78.8M 0.16% 106

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harris Associates's MRK Position: Q1 2026 in Review

Harris Associates reduced its Merck (MRK) stake by 12% in Q1 2026, selling an estimated $199M and leaving 12,366,933 shares worth $1.49B. The position accounts for 1.98% of the portfolio, ranked #15.

Harris Associates first reported a position in MRK in Q2 2013 and has held it in 15 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Harris Associates held 12,366,933 shares of Merck worth $1.49B as of Q1 2026.
  • Harris Associates sold 1,721,772 Merck shares in Q1 2026, an estimated $199M.
  • Merck made up 1.98% of Harris Associates's portfolio in Q1 2026, its #15 holding.
  • Harris Associates first reported a position in Merck in Q2 2013 and has held it in 15 quarters since.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Harris Associates's 13F filing for Q1 2026, filed 15 May 2026.